ACT Lung Health Intervention: Phase Two

Dana-Farber Cancer Institute

Status: Enrolling

Conditions: Smoking (Tobacco) Addiction; Smoking, Cigarette; Smoking, Tobacco; Smoking Behaviors; Smoking Cessation

Treatments: Behavioral: ACT Lung Health Intervention

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06945120

25-041

5U54CA156732-14 (U.S. NIH Grant/Contract)

5U54CA156734-14 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Full description

This two-arm stratified randomized clinical trial is to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Participants will be randomized into one of two groups: Group A: ACT Lung Health Intervention versus Group B: Standard Care. Randomization means a participant is placed into a study group by chance.

The research study procedures include screening for eligibility, questionnaires, and saliva tests.

It is expected participation in this study will last about 6 months.

About 50 participants are expected to take part in this research study.

The National Cancer Institute is providing funding for this trial.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Self-identify as either Chinese or Korean
• Speak either Korean, Mandarin, or English
• Are 18 years of age or older
• Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days)
• Will live in the United States for the next 12 months

Exclusion criteria

• Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.

• We will not include any of the following special populations:

  • Adults unable to consent.
  • Adults younger than 50 or older than 80 years
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

50 participants in 2 patient groups

Group A: ACT Lung Health Intervention

Experimental group

Description:

Participants will be randomized 1:1 in blocks, stratified by ethnicity and readiness to quit smoking and will complete: * Baseline assessment * Eight telephone or video counseling sessions over 8 weeks * Nicotine replacement therapy (NRT) patches, gums and lozenges will be provided * Written educational materials on lung cancer screening will be provided * Assessments at 1, 3, and 6 months * 3 month saliva test * 6 month saliva test

Treatment:

Behavioral: ACT Lung Health Intervention

Group B: Standard Care

No Intervention group

Description:

Participants will be randomized 1:1 in blocks, stratified by ethnicity and readiness to quit smoking and will complete: * Baseline assessment * Six telephone or video counseling sessions over 8 weeks * Nicotine replacement therapy (NRT) patches, gums and lozenges will be provided * Written educational materials on lung cancer screening will be provided * Assessments at 1, 3, and 6 months * 3 month saliva test * 6 month saliva test